PROCESSA PHARMACEUTICALS INC's ticker is PCSA and the CUSIP is 74275C205.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13 | -43.5% | 53,900 | +18.7% | 0.00% | – |
Q2 2023 | $23 | +43.8% | 45,400 | +45.5% | 0.00% | – |
Q1 2023 | $16 | 0.0% | 31,200 | +121.3% | 0.00% | – |
Q4 2022 | $16 | -99.9% | 14,100 | +20.5% | 0.00% | – |
Q3 2022 | $26,000 | -21.2% | 11,700 | +0.9% | 0.00% | – |
Q2 2022 | $33,000 | – | 11,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Solas Capital Management, LLC | 196,150 | $961,000 | 0.68% |
AIGH Capital Management LLC | 303,703 | $1,488,000 | 0.45% |
Worth Venture Partners, LLC | 70,954 | $348,000 | 0.17% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 73,180 | $359,000 | 0.04% |
Verdence Capital Advisors LLC | 63,227 | $310,000 | 0.04% |
Coastal Bridge Advisors, LLC | 32,500 | $159,000 | 0.03% |
Vectors Research Management, LLC | 4,000 | $20,000 | 0.00% |
Janney Montgomery Scott LLC | 46,231 | $227,000 | 0.00% |
NORTHERN TRUST CORP | 15,401 | $75,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |